Companies / CHM

CHIMERIC THERAPEUTICS LIMITED

ASX:CHMPharmaceuticals, Biotechnology & Life Sciences
95.9M shares on issueASX (delayed) · snapshot 11 Sept 2026114.4M fully diluted+19.2% if every option and right converts$0.008price · delayed$767kmarket cap · indicative

Today’s holders own 83.9% of what they think they own, once every option and right converts.

Very high
Dilution risk

Runway under 2 quarters; share count grew 973% in 24 months; 9 cash raises in 24 months

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway-0.1 quarters of funding
Share-count growth (24m)973.2%
Raise cadence (24m)9 cash raises
Options & rights overhang19.2% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

CHIMERIC THERAPEUTICS LIMITED underwent an approximately 1-for-100 share consolidation in April 2026. Following this, its ordinary share count grew 973.2% between August 2024 and September 2026, to 96M shares. The company raised capital nine times in the past 24 months, for total disclosed proceeds of A$4.8M, with the latest being a placement in December 2025. Options on issue could convert to 18M new shares, representing 19.2% of the current share count; the nearest expiry date for these options is October 2028. As of June 2026, the company reported A$-481K in available cash, covering approximately -0.1 quarters of its operational expenses. No proposed securities issues are currently pending.

AI-generated summary of this page's cited filings · updated 11 Sept 2026
Get told when this changes
Set up alerts
Daily email alerts cover risk-level moves, new raises, pending proposed issues and option expiries for the companies you follow.
19.2%
Options & rights overhang
0.0%
In-the-money supply
1
Raises · last 12 months
-0.1 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Adjusted for the 1-for-100 consolidation (20 Apr 2026). Latest count 95.9M per ASX (delayed) (snapshot 11 Sept 2026).
25M50M75M100MDec 24Oct 25Sept 261-for-100 consolidationCash raise · 23 Dec 2025Cash raise · 24 July 2025Cash raise · 15 May 2025Cash raise · 9 May 2025Cash raise · 17 Mar 2025Cash raise · 17 Mar 2025Cash raise · 4 Mar 2025Cash raise · 3 Mar 2025Cash raise · 10 Feb 202595.9M

Cash runway

-0.1 qtrs
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
$-520k cash after burn from the quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds. Filed with the quarterly report: $800k cash at quarter end (item 4.6), 0.2 qtrs of funding on the company’s own estimate. Our figure above carries the filed quarter-end balance forward at the reported spend rate and adds announced raise proceeds.
Free account
13 quarters on record — Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
4 Sept 20262A · quoted issueCHM : ORDINARY FULLY PAID95.9MAppendix 2A
27 Aug 20262A · quoted issueCHM : ORDINARY FULLY PAID81.1MAppendix 2A
21 Aug 20262A · quoted issueCHM : ORDINARY FULLY PAID70.8MAppendix 2A
7 Aug 20262A · quoted issueCHM : ORDINARY FULLY PAID61.3MAppendix 2A
22 July 20262A · quoted issueCHM : ORDINARY FULLY PAID59.5MAppendix 2A
Free account
68 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Capital raises

9 cash raises in the last 24 months · 1 in the last 12 months

every 1.5 monthsaverage gap between raises
8.6 monthssince the most recent
10 Feb 2025 – 23 Dec 2025first to most recent in this window
—
Placement
23 Dec 2025 ACTIVE
Free account
12 raises on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account
3 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.

No estimate — a share consolidation inside the last 12 months puts the filings and the share count in different units.
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

19.2%
Options & rights overhang · of current shares
0.0%
In-the-money supply · at current price
18.5M
Potential new shares
Oct 2028
Nearest expiry
What this supply is, and what converts it
  • Price-triggered18.4M · 19.2% of shares
    Options and warrants — they convert when the share price clears their exercise price.
    At least 3.0M of it states no exercise price — that much cannot be called in or out of the money.
  • Condition-triggered72k · 0.1% of shares
    Performance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
  • Converts on terms600 · 0.0% of shares
    Convertibles with no exercise price — they convert on their own terms, so they are shares in all but name.

Exercise price on record: 15.4M priced, 3.0M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.

Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.

What a price move would switch on
9.2M18.5M$0.008 now0.25× today ($0.002) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($0.004) — 0 of the priced supply in the money, 0.0% of shares on issue0.75× today ($0.006) — 0 of the priced supply in the money, 0.0% of shares on issue1× today ($0.008) — 0 of the priced supply in the money, 0.0% of shares on issue1.25× today ($0.010) — 0 of the priced supply in the money, 0.0% of shares on issue1.5× today ($0.012) — 0 of the priced supply in the money, 0.0% of shares on issue2× today ($0.016) — 0 of the priced supply in the money, 0.0% of shares on issue3× today ($0.024) — 0 of the priced supply in the money, 0.0% of shares on issue5× today ($0.040) — 0 of the priced supply in the money, 0.0% of shares on issue10× today ($0.080) — 0 of the priced supply in the money, 0.0% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

At $0.008 today, 0 securities are in the money (0.0% of shares on issue). No price up to ten times today’s switches on any more priced supply.

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
  • 3.0M (16.4% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
  • 15.4M more carries an exercise price above ten times today’s — off the right of this axis, and in every total on this page.
CodeSecurityTypeExercise priceExpiryOn issueSource
CHMAAHOptionsPrice-triggered$0.8010 Oct 2028250kFiling
CHMAAJOptionsPrice-triggered$0.6031 Mar 2029500kFiling
CHMAAIOptionsPrice-triggered$0.5031 Dec 203014.7MFiling
CHMAAKNotesConverts on terms——600Filing
CHMAALWarrantsPrice-triggered——700Filing
CHMAABPerformance rightsCondition-triggered——72kFiling Meeting
CHMAYOptionsPrice-triggered——3.0MFiling

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.

A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.

Free account
7 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
19 Dec 2025Miles PrinceOther—16.7M——3Y notice
19 Aug 2025Miles PrinceBuy on-market4.3M———3Y notice
26 June 2025Lesley RussellSell—2.8M——3Y notice
Free account
5 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

4 Sept 2026Application for quotation of securities - CHM
31 Aug 2026$PAppendix 4E and Preliminary Final Report
27 Aug 2026Application for quotation of securities - CHM
21 Aug 2026Application for quotation of securities - CHM
18 Aug 2026$PCHM ceases enrolment in Phase 1 trial and Company update
16 Aug 2026$PTrading Halt
7 Aug 2026Application for quotation of securities - CHM
31 July 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
29 July 2026$PChimeric receives $1.62M advance on FY26 R&D tax incentive
28 July 2026Investor Presentation
22 July 2026Application for quotation of securities - CHM
17 July 2026Notification regarding unquoted securities - CHM
17 July 2026Notification regarding unquoted securities - CHM
15 July 2026$PCHM CDH17 Phase 1 clinical trial update - New DL 3 data
14 July 2026Application for quotation of securities - CHM
14 July 2026Notification of cessation of securities - CHM
7 July 2026Final Director's Interest Notice
5 July 2026Board Update
2 July 2026Application for quotation of securities - CHM
30 June 2026$PAppointment of Financial Adviser for Strategic Review

Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.